Home » FDA Creates Coronavirus Treatment Acceleration Program
FDA Creates Coronavirus Treatment Acceleration Program
The FDA launched the Coronavirus Treatment Acceleration Program (CTAP), an emergency program for potential COVID-19 therapies.
The agency has deployed staff specifically to reviewing COVID-19 therapies.
The agency is currently monitoring 10 therapies in active trials and 15 others in planning stages.
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May